Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
Ontology highlight
ABSTRACT: This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing the occurrence of new colorectal adenomas post-polypectomy at Month 13 (Year 1) and Month 37 (Year 3) of study drug administration.
DISEASE(S): Adenomatous Polyps,Colorectal Adenoma,Adenoma,Malignant Neoplasm Of Colon
PROVIDER: 2015085 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA